6-116616612-T-TCCA

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP6BS1BS2

The NM_001010892.3(RSPH4A):​c.-12_-11insCCA variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000796 in 1,606,248 control chromosomes in the GnomAD database, including 9 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0044 ( 4 hom., cov: 31)
Exomes 𝑓: 0.00042 ( 5 hom. )

Consequence

RSPH4A
NM_001010892.3 5_prime_UTR

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: -0.219

Publications

0 publications found
Variant links:
Genes affected
RSPH4A (HGNC:21558): (radial spoke head component 4A) This gene encodes a protein that appears to be a component the radial spoke head, as determined by homology to similar proteins in the biflagellate alga Chlamydomonas reinhardtii and other ciliates. Radial spokes, which are regularly spaced along cilia, sperm, and flagella axonemes, consist of a thin 'stalk' and a bulbous 'head' that form a signal transduction scaffold between the central pair of microtubules and dynein. Mutations in this gene cause primary ciliary dyskinesia 1, a disease arising from dysmotility of motile cilia and sperm. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
RSPH4A Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 11
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP6
Variant 6-116616612-T-TCCA is Benign according to our data. Variant chr6-116616612-T-TCCA is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 1706779.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Likely_benign=1}.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00438 (666/152212) while in subpopulation AFR AF = 0.0151 (626/41494). AF 95% confidence interval is 0.0141. There are 4 homozygotes in GnomAd4. There are 311 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RSPH4ANM_001010892.3 linkc.-12_-11insCCA 5_prime_UTR_variant Exon 1 of 6 ENST00000229554.10 NP_001010892.1 Q5TD94-1B3KTA9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RSPH4AENST00000229554.10 linkc.-12_-11insCCA 5_prime_UTR_variant Exon 1 of 6 1 NM_001010892.3 ENSP00000229554.5 Q5TD94-1
RSPH4AENST00000368581.8 linkc.-12_-11insCCA 5_prime_UTR_variant Exon 1 of 5 1 ENSP00000357570.4 Q5TD94-3
RSPH4AENST00000368580.4 linkc.-12_-11insCCA upstream_gene_variant 5 ENSP00000357569.4 Q5TD94-2

Frequencies

GnomAD3 genomes
AF:
0.00440
AC:
669
AN:
152094
Hom.:
4
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0152
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00223
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.000598
AC:
142
AN:
237604
AF XY:
0.000536
show subpopulations
Gnomad AFR exome
AF:
0.00815
Gnomad AMR exome
AF:
0.000661
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000944
Gnomad OTH exome
AF:
0.000342
GnomAD4 exome
AF:
0.000421
AC:
612
AN:
1454036
Hom.:
5
Cov.:
31
AF XY:
0.000363
AC XY:
262
AN XY:
722654
show subpopulations
African (AFR)
AF:
0.0147
AC:
489
AN:
33356
American (AMR)
AF:
0.00108
AC:
47
AN:
43468
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25960
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39568
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85424
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53110
Middle Eastern (MID)
AF:
0.000708
AC:
4
AN:
5652
European-Non Finnish (NFE)
AF:
0.0000154
AC:
17
AN:
1107342
Other (OTH)
AF:
0.000914
AC:
55
AN:
60156
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
33
66
99
132
165
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00438
AC:
666
AN:
152212
Hom.:
4
Cov.:
31
AF XY:
0.00418
AC XY:
311
AN XY:
74416
show subpopulations
African (AFR)
AF:
0.0151
AC:
626
AN:
41494
American (AMR)
AF:
0.00222
AC:
34
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68024
Other (OTH)
AF:
0.00237
AC:
5
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
35
70
106
141
176
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00244
Hom.:
0
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia Uncertain:1
Aug 26, 2015
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

not provided Benign:1
Jul 11, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.22
Mutation Taster
=300/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs576610212; hg19: chr6-116937775; API